Seroquel STACK Study in Schizophrenic or Schizoaffective Subjects
Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess and compare the side effect profile, safety,
tolerability and efficacy of schizophrenic or schizoaffective subjects non- or partially-
responsive to 800 mg/day of quetiapine treated with either 800 mg/day or more than 800 mg/day
of quetiapine during 8 weeks.